Display options
Share it on

Prev Med Rep. 2019 Jul 22;16:100961. doi: 10.1016/j.pmedr.2019.100961. eCollection 2019 Dec.

Diabetes Prevention Program attendance is associated with improved patient activation: Results from the Prediabetes Informed Decisions and Education (PRIDE) study.

Preventive medicine reports

Kia Skrine Jeffers, Yelba Castellon-Lopez, Jonathan Grotts, Carol M Mangione, Tannaz Moin, Chi-Hong Tseng, Norman Turk, Dominick L Frosch, Keith C Norris, Christopher C Duke, Gerardo Moreno, O Kenrik Duru

Affiliations

  1. School Nursing, UCLA, Los Angeles, CA, United States of America.
  2. Department of Family Medicine, David Geffen School of Medicine, UCLA, Los Angeles, CA, United States of America.
  3. Division of General Internal Medicine and Health Services Research, David Geffen School of Medicine, UCLA, Los Angeles, CA, United States of America.
  4. Jonathan and Karin Fielding School of Public Health, UCLA, Los Angeles, CA, United States of America.
  5. Veterans Affairs Greater Los Angeles Health System, Veterans Affairs Health Services Research and Development Service Center for the Study of Healthcare Innovation, Implementation & Policy, United States of America.
  6. Palo Alto Medical Foundation, Palo Alto, CA, United States of America.
  7. Altarum Institute, Ann Arbor, MI, United States of America.

PMID: 31516814 PMCID: PMC6732720 DOI: 10.1016/j.pmedr.2019.100961

Abstract

The Diabetes Prevention Program (DPP) is a 12-month behavior change program designed to increase physical activity and improve dietary patterns among patients at risk for Type 2 diabetes, in order to facilitate modest weight loss and improve cardio-metabolic profiles. It is unknown whether baseline patient activation is related to increased DPP uptake, and whether DPP attendance leads to subsequent improvement in patient activation. We analyzed data from 352 adult participants in the Prediabetes Informed Decisions and Education (PRIDE) trial of shared decision-making (SDM) in diabetes prevention, collected from November 2015 through September 2017. PRIDE participants completed baseline and 4-month follow-up surveys, including the Altarum Consumer Engagement (ACE) Measure™ of patient activation. We tracked DPP attendance over 8 months using data from partnering DPP providers. In multivariate models, we measured whether self-reported baseline activation was associated with DPP "uptake" (1+ session attended) or DPP "attendance" (9+ sessions). We also examined whether DPP attendance was associated with change in activation at 4-months follow-up. We did not find an association between baseline activation and DPP uptake or attendance. However, we did find that DPP attendance was associated with an increase in the overall ACE score (6.68 points, 95% CI 1.97-11.39,

Keywords: Diabetes Prevention Program; Diabetes mellitus; Pharmacists; Shared decision-making

Conflict of interest statement

No conflicts of interests were reported by the authors of this paper.

References

  1. J Gen Intern Med. 2001 Sep;16(9):606-13 - PubMed
  2. N Engl J Med. 2002 Feb 7;346(6):393-403 - PubMed
  3. Health Serv Res. 2004 Aug;39(4 Pt 1):1005-26 - PubMed
  4. Eur J Public Health. 2007 Oct;17(5):455-63 - PubMed
  5. BMC Health Serv Res. 2010 May 07;10:114 - PubMed
  6. Scand J Public Health. 2011 May;39(3):262-71 - PubMed
  7. Diabet Med. 2014 Aug;31(8):976-86 - PubMed
  8. Health Aff (Millwood). 2015 Mar;34(3):431-7 - PubMed
  9. Patient. 2015 Dec;8(6):559-68 - PubMed
  10. Lancet Diabetes Endocrinol. 2015 Nov;3(11):866-75 - PubMed
  11. Implement Sci. 2015 Dec 15;10:172 - PubMed
  12. PLoS Med. 2016 Jul 26;13(7):e1002095 - PubMed
  13. Patient Prefer Adherence. 2016 Aug 12;10:1547-59 - PubMed
  14. Fed Regist. ;81(220):80170-562 - PubMed
  15. Transl Behav Med. 2017 Jun;7(2):385-387 - PubMed
  16. Patient Educ Couns. 2017 Jul;100(7):1268-1275 - PubMed
  17. Health Educ Behav. 2017 Apr;44(2):236-244 - PubMed
  18. Diabetes Care. 2017 Oct;40(10):1331-1341 - PubMed
  19. Clin Diabetes. 2018 Oct;36(4):295-304 - PubMed

Publication Types

Grant support